Gujarat Themis Biosyn is currently trading at Rs. 45.00, up by 1.60 points or 3.69% from its previous closing of Rs. 43.40 on the BSE.
The scrip opened at Rs. 44.95 and has touched a high and low of Rs. 45.00 and Rs. 44.95 respectively. So far 2150 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 45.90 on 23-Sep-2019 and a 52 week low of Rs. 28.15 on 13-Feb-2019.
Last one week high and low of the scrip stood at Rs. 45.90 and Rs. 42.00 respectively. The current market cap of the company is Rs. 63.05 crore.
The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 0.03% and 24.97% respectively.
Gujarat Themis Biosyn has implemented its new business model of manufacturing and supply of pharmaceutical products to various parties.
Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company. The company’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States.
